CD83 and Alzheimer disease: Given that CD83 is a marker of mature dendritic cells, with complex, bidirectional interactions between CD83 and diverse pathogens43–45, we hypothesized that CD83(+) AD subjects may differ from CD83(−) AD subjects on the basis of microbial or immunological perturbation which could be occurring peripherally, including during end-stage dementia.